One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
New Insights Into Major Depression and the Treatment of Bipolar Depression
Ned H. Kalin, M.D.
doi : 10.1176/appi.ajp.2021.21101042
Volume 178, Issue 12
Slowly Working Toward More Treatments for Depression in Bipolar II Disorder
Michael J. Ostacher, M.D., M.P.H.
Increased Inflammation in Depression: A Little in All, or a Lot in a Few?
Carmine M. Pariante, M.D., Ph.D.
Coordinate Network Mapping: An Emerging Approach for Morphometric Meta-Analysis
Joseph J. Taylor, M.D., Ph.D., Shan H. Siddiqi, M.D., Michael D. Fox, M.D., Ph.D.
Neuromodulation Strategies for the Treatment of Depression
Susan K. Conroy, M.D., Ph.D., Paul E. Holtzheimer, M.D.
Association of ECT With Risks of All-Cause Mortality and Suicide in Older Medicare Patients
Taeho Greg Rhee, Ph.D., Kyaw Sint, Ph.D., Mark Olfson, M.D., M.P.H., Tobias Gerhard, Ph.D., Susan H. Busch, Ph.D., Samuel T. Wilkinson, M.D.
Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial
Joseph R. Calabrese, M.D., Suresh Durgam, M.D., Andrew Satlin, M.D., Kimberly E. Vanover, Ph.D., Robert E. Davis, Ph.D., Richard Chen, Ph.D., Susan G.
Association Between Systemic Inflammation and Individual Symptoms of Depression: A Pooled Analysis of 15 Population-Based Cohort Studies
Philipp Frank, M.Sc., Markus Jokela, Ph.D., G. David Batty, Ph.D., D.Sc., Dorina Cadar, Ph.D., Andrew Steptoe, D.Phil., F.Med.Sci., Mika Kivim?ki, Ph.
Coordinate-Based Network Mapping of Brain Structure in Major Depressive Disorder in Younger and Older Adults: A Systematic Review and Meta-Analysis
Peter Zhukovsky, Ph.D., John A.E. Anderson, Ph.D., Gillian Coughlan, Ph.D., Benoit H. Mulsant, M.D., M.S., Andrea Cipriani, M.D., Ph.D., Aristotle N.
Recommendations for the Usage of Ketamine and Esketamine
Victor I. Reus, M.D.
Mechanisms of Action of Ketamine and Esketamine
Alan F. Schatzberg, M.D.
Ketamine and Esketamine for Treatment-Resistant Depression: Response to Reus, Mattes, and Schatzberg
Roger S. McIntyre, M.D.
